You are currently viewing a new version of our website. To view the old version click .

Current Oncology, Volume 30, Issue 12

December 2023 - 41 articles

Cover Story: Epithelial ovarian cancer is a heterogeneous group of malignancies. While BRCA variants elevate the risk of ovarian cancer, most cases occur in individuals without any known genetic variants, necessitating prevention strategies for people without known high-risk genetic variants. Opportunistic salpingectomy, removing fallopian tubes during planned pelvic surgery, is an emerging primary prevention strategy. Evidence of effectiveness has emerged in patients who underwent opportunistic salpingectomy for cancer prevention. This, coupled with an increased understanding of precursor lesions, has turned attention towards broadening opportunities for salpingectomy, as well as offering fallopian tube removal to people at higher-than-average lifetime risk for ovarian cancer despite not having a known genetic mutation that increases their risk. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (41)

  • Article
  • Open Access
1 Citations
2,853 Views
12 Pages

4 December 2023

This research aimed to assess the relationship between contrast-enhanced (CE) magnetic resonance fingerprinting (MRF) values and dynamic contrast-enhanced (DCE) MRI parameters including (Ktrans, Kep, Ve, and iAUC). To evaluate the correlation between...

  • Review
  • Open Access
8 Citations
3,225 Views
16 Pages

Incorporating Stereotactic Ablative Radiotherapy into the Multidisciplinary Management of Renal Cell Carcinoma

  • Rohit K. Raj,
  • Rituraj Upadhyay,
  • Shang-Jui Wang,
  • Eric A. Singer and
  • Shawn Dason

1 December 2023

Stereotactic ablative radiotherapy (SABR) has challenged the conventional wisdom surrounding the radioresistance of renal cell carcinoma (RCC). In the past decade, there has been a significant accumulation of clinical data to support the safety and e...

  • Article
  • Open Access
1 Citations
2,471 Views
11 Pages

Combined Interval Cytoreductive Surgery and Carboplatin-Based Hyperthermic Intraperitoneal Chemotherapy in Advanced Primary High-Grade Serous Ovarian Cancer

  • Claudèle Brault,
  • Alexandre Brind’Amour,
  • Lara de Guerke,
  • Marie-Hélène Auclair,
  • Lucas Sideris,
  • Pierre Dubé,
  • Mikaël Soucisse,
  • Jean-François Tremblay,
  • Laurence Bernard and
  • Sabrina Piedimonte
  • + 1 author

1 December 2023

Combining interval cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) improves survival in advanced epithelial ovarian carcinoma (EOC). Although limited, growing evidence regarding carboplatin-based HIPEC highlights it...

  • Case Report
  • Open Access
2,149 Views
12 Pages

30 November 2023

Psammocarcinoma (PsC) represents a rare form of low-grade serous tumor of the ovary or peritoneum. Although ovarian cancer generally has a poor prognosis in its late stages, PsC seems to have a more indolent course. We present a patient with a histor...

  • Article
  • Open Access
3 Citations
2,610 Views
11 Pages

Breakthrough and Episodic Cancer Pain from a Palliative Care Perspective

  • Erik Torbjørn Løhre,
  • Gunnhild Jakobsen,
  • Tora Skeidsvoll Solheim,
  • Pål Klepstad and
  • Morten Thronæs

30 November 2023

Cancer pain intensity (PI) fluctuates, but the relationship between pain flares and background pain with respect to pain management is not settled. We studied how flare and background PIs corresponded with treatment results for background cancer pain...

  • Case Report
  • Open Access
10 Citations
3,350 Views
12 Pages

Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature Review

  • Poupak Fallahi,
  • Armando Patrizio,
  • Giulio Stoppini,
  • Giusy Elia,
  • Francesca Ragusa,
  • Sabrina Rosaria Paparo,
  • Eugenia Balestri,
  • Valeria Mazzi,
  • Chiara Botrini and
  • Gilda Varricchi
  • + 4 authors

30 November 2023

Background: Papillary thyroid carcinoma (PTC) is the most common type of differentiated TC, while medullary TC (MTC) accounts for 4%. The concomitant presence of PTC and MTC is rare. Methods: This is a retrospective, single-center observational study...

  • Review
  • Open Access
1 Citations
3,853 Views
13 Pages

30 November 2023

The development and use of oral anticancer agents (OAAs) continue to grow, and supporting individuals on OAAs is now a priority as they find themselves taking these drugs at home with little professional guidance. This mapping review provides an over...

  • Review
  • Open Access
23 Citations
7,278 Views
13 Pages

Sequencing Antibody Drug Conjugates in Breast Cancer: Exploring Future Roles

  • Mary Anne Fenton,
  • Paolo Tarantino and
  • Stephanie L. Graff

29 November 2023

Antibody drug conjugates (ADCs) have emerged as a highly effective treatment strategy across breast cancer (BC) subtypes, including human epidermal growth factor receptor 2-positive (HER2+), hormone-receptor positive (ER/PR+), and triple-negative bre...

  • Article
  • Open Access
2 Citations
3,112 Views
16 Pages

Feasibility Randomised Control Trial of OptiMal: A Self-Management Intervention for Cancer Survivors

  • Lauren Boland,
  • Kathleen E. Bennett,
  • Sinead Cuffe,
  • Cliona Grant,
  • M. John Kennedy and
  • Deirdre Connolly

29 November 2023

Purpose: Cancer survivors can experience symptoms such as fatigue, pain and distress that persist for many months following treatment. These enduring symptoms often impact on participation in self-care activities, returning to school and/or work, and...

  • Review
  • Open Access
19 Citations
4,498 Views
16 Pages

Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention Programs

  • Ramlogan Sowamber,
  • Alexandra Lukey,
  • David Huntsman and
  • Gillian Hanley

29 November 2023

Epithelial ovarian cancer (EOC) is a heterogeneous group of malignancies, including high-grade serous ovarian cancer (HGSC). HGSC is often diagnosed at advanced stages and is linked to TP53 variants. While BRCA variants elevate risk, most HGSC cases...

of 5

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729